Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
Labcorp agreed to acquire select assets of BioReference Health from OPKO Health for $722 million in cash, plus up to $150 million in an earnout tied to 4Kscore Test revenue. The deal adds clinical, women's health, urology and corrections testing businesses, over 80 patient service centers, and the FDA-approved 4Kscore prostate cancer blood test.
Key figures
- Deal Value Usd
- 722000000
- Earnout potential
- $150 million (4Kscore revenue-based)
- Patient service centers
- over 80
- Expected first year revenue
- 250000000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.